Details van artikel 244 van 257 gevonden artikelen
90TiP Adjuvant study of amcenestrant (SAR439859) versus tamoxifen for patients with hormone receptor-positive (HR+) early breast cancer (EBC), who have discontinued adjuvant aromatase inhibitor therapy due to treatment-related toxicity (AMEERA-6)
Titel:
90TiP Adjuvant study of amcenestrant (SAR439859) versus tamoxifen for patients with hormone receptor-positive (HR+) early breast cancer (EBC), who have discontinued adjuvant aromatase inhibitor therapy due to treatment-related toxicity (AMEERA-6)
Auteur:
Rossi, G. Brain, E. Dueck, A. De Swert, H. Marreaud, S.I. Partridge, A. Herold, C. Vachon, H. Spanic, T. Arahmani, A. Verbiest, T. Wang, L. Goulioti, T. Malanda, B. Carey, L.A. Anneheim, S. Paux, G. Poncet, C. Metzger, O. Cameron, D.
Verschenen in:
Annals of oncology
Paginering:
Jaargang 33 () nr. S3 pagina's S162-S163
Jaar:
2022
Inhoud:
Uitgever:
European Society for Medical Oncology
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 244 van 257 gevonden artikelen